Figure 2
From: Smart pooling: AI-powered COVID-19 informative group testing

Smart Pooling decreases the expected number of tests per specimen. (a) Smart Pooling’s expected number of tests per specimen compared to standard testing methods on Patient Dataset. Efficiency improves by reducing the expected number of tests per specimen. Smart Pooling achieves higher efficiencies than Dorfman’s and individual testing for prevalences of the disease of up to 50%, with a fixed pool size of 10. (b) Smart Pooling’s expected number of tests per specimen trained with the coarse metadata from the Test Center Dataset. Efficiency improves by reducing the expected number of tests per specimen. Despite not having detailed patient metadata, Smart Pooling can produce higher efficiencies than Dorfman’s pooling for the simulated prevalence of the disease of up to 25%, with a fixed pool size of 10. (c) Expected number of tests per specimen for the proof-of-concept Smart Pooling Implementation. Each point on the graph represents the performance of both methods for a day in the proof-of-concept stage. The x-axis depicts the incidence of the corresponding day. Efficiency improves by reducing the expected number of tests per specimen. Smart Pooling has a similar efficiency compared to Dorfman’s testing since the daily incidence is lower than 10%. However, for every day of the implementation, Smart Pooling has a higher efficiency than individual testing.